1. Home
  2. WEAV vs CATX Comparison

WEAV vs CATX Comparison

Compare WEAV & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weave Communications Inc.

WEAV

Weave Communications Inc.

N/A

Current Price

$7.33

Market Cap

413.7M

Sector

Technology

ML Signal

N/A

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

N/A

Current Price

$2.88

Market Cap

355.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WEAV
CATX
Founded
2011
1983
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
413.7M
355.0M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
WEAV
CATX
Price
$7.33
$2.88
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
9
Target Price
$11.00
$12.11
AVG Volume (30 Days)
3.1M
1.1M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
7.50
N/A
EPS
N/A
N/A
Revenue
$239,024,000.00
N/A
Revenue This Year
$17.20
N/A
Revenue Next Year
$13.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.99
N/A
52 Week Low
$4.24
$1.96
52 Week High
$7.98
$6.16

Technical Indicators

Market Signals
Indicator
WEAV
CATX
Relative Strength Index (RSI) 63.04 34.74
Support Level $6.94 $2.25
Resistance Level $7.33 $2.96
Average True Range (ATR) 0.02 0.15
MACD -0.02 -0.05
Stochastic Oscillator 56.43 1.69

Price Performance

Historical Comparison
WEAV
CATX

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and generates revenue mainly from subscriptions.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: